2 hours ago
AbbVie (ABBV) Gets $260 Price Target Upgrades Amid Growing Valuation Worries
AbbVie (ABBV) receives $260 price target upgrades from Citi and UBS, but Neutral ratings persist as Zacks flags Sell and valuation concerns emerge.
The post AbbVie (ABBV) Gets $260 Price Target Upgrades Amid Growing Valuation Worries appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
SK Hynix (SKHY) vs Micron (MU): Which AI Memory Stock Should You Choose in 2026?
- 1 hour ago
Nexstar Media (NXST) Stock Jumps 8.75% on FCC Deregulation News
- 1 hour ago
Rocket Lab (RKLB) Stock: Analyst Confidence Holds Despite CEO’s $110M Share Sale
- 1 hour ago
Strategy (MSTR) Stock: Bitcoin Would Need 85% Crash to Trigger Balance Sheet Con...
- 2 hours ago
Faraday Future (FFAI) Stock Climbs on Expanded AI Robotics Education Initiative...